Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CVS
|
J. David Joyner
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,203 Reduced 16.85% |
$683,691
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
David M Denton
EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 110,095 Added 37.74% |
$8,178,958
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
David M Denton
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 6,857 Reduced 7.31% |
$509,407
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
Stephen J Gold
EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct | 25,575 Added 44.78% |
$1,899,967
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
Eva C Boratto
EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 3,028 Added 11.85% |
$224,950
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
Andrew Sussman
EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct | 4,711 Added 16.81% |
$349,980
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
Larry J Merlo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 53,843 Added 16.98% |
$3,999,997
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
Jonathan C Roberts
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 11,778 Added 16.09% |
$874,988
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
Jonathan C Roberts
EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,026 Reduced 6.04% |
$150,512
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
Lisa Bisaccia
Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,384 Added 16.09% |
$399,977
$74.29 p/Share
|
Apr 01
2014 |
CVS
|
Lisa Bisaccia
Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,086 Reduced 11.74% |
$229,259
$74.29 p/Share
|
Apr 01
2014 |
LGF-B
|
Frank Giustra
Director |
BUY
Grant, award, or other acquisition
|
Direct | 347 Added 0.32% |
$9,057
$26.1 p/Share
|
Apr 01
2014 |
LGF-B
|
Phyllis Yaffe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 907 Added 2.98% |
$23,673
$26.1 p/Share
|
Apr 01
2014 |
LGF-B
|
Morley Koffman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 736 Added 0.9% |
$19,210
$26.1 p/Share
|
Apr 01
2014 |
LGF-B
|
Hardwick Simmons
Director |
BUY
Grant, award, or other acquisition
|
Direct | 843 Added 0.94% |
$22,002
$26.1 p/Share
|
Apr 01
2014 |
LGF-B
|
Harald Ludwig
Director |
BUY
Grant, award, or other acquisition
|
Direct | 347 Added 0.26% |
$9,057
$26.1 p/Share
|
Apr 01
2014 |
LGF-B
|
Scott Paterson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,109 Added 0.41% |
$28,945
$26.1 p/Share
|
Apr 01
2014 |
LGF-B
|
Daryl Simm |
BUY
Grant, award, or other acquisition
|
Direct | 506 Added 0.77% |
$13,207
$26.1 p/Share
|
Apr 01
2014 |
LGF-B
|
Arthur Evrensel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 518 Added 0.88% |
$13,520
$26.1 p/Share
|
Apr 01
2014 |
LGF-B
|
Mark H Md Rachesky |
BUY
Grant, award, or other acquisition
|
Direct | 4,161 Added 8.22% |
-
|
Apr 01
2014 |
AMT
|
Edmund Di Santo |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 43.09% |
$4,080,000
$81.6 p/Share
|
Apr 01
2014 |
AMT
|
Edmund Di Santo |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 30.11% |
$2,147,500
$42.95 p/Share
|
Apr 01
2014 |
LOW
|
Gaither M Keener Jr
EVP Legal |
SELL
Bona fide gift
|
Direct | 1,800 Reduced 2.87% |
-
|
Apr 01
2014 |
NKE
|
John C Lechleiter
Director |
BUY
Open market or private purchase
|
Direct | 750 Added 9.09% |
$55,748
$74.33 p/Share
|
Apr 01
2014 |
ADBE
|
Charles M Geschke
Director |
SELL
Open market or private sale
|
Indirect | 33,500 Reduced 10.96% |
$2,205,305
$65.83 p/Share
|
Apr 01
2014 |
ADBE
|
Charles M Geschke
Director |
BUY
Exercise of conversion of derivative security
|
Indirect | 50,000 Added 14.06% |
$1,486,500
$29.73 p/Share
|
Apr 01
2014 |
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 16.2% |
$3,300,000
$66.0 p/Share
|
Apr 01
2014 |
ADBE
|
Shantanu Narayen
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 50,000 Added 7.61% |
$1,364,500
$27.29 p/Share
|
Apr 01
2014 |
ADBE
|
Mark Garrett
EVP, CFO & Asst. Secretary |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 85.7% |
$990,300
$66.02 p/Share
|
Apr 01
2014 |
ORCL
|
Mark V Hurd
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 500,000 Reduced 99.8% |
$20,790,001
$41.58 p/Share
|
Apr 01
2014 |
ORCL
|
Mark V Hurd
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 500,000 Added 49.95% |
$12,070,000
$24.14 p/Share
|
Apr 01
2014 |
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Bona fide gift
|
Direct | 219 Reduced 0.09% |
-
|
Apr 01
2014 |
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Open market or private sale
|
Indirect | 219 Reduced 0.2% |
$4,054
$18.51 p/Share
|
Apr 01
2014 |
NVDA
|
David M Shannon
EVP, CAO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 219 Added 0.09% |
$2,190
$10.0 p/Share
|
Apr 01
2014 |
NVDA
|
David M Shannon
EVP, CAO & Secretary |
BUY
Bona fide gift
|
Indirect | 219 Added 0.2% |
-
|
Apr 01
2014 |
PRSO
|
James Sullivan
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,461 Reduced 4.51% |
$6,837
$4.68 p/Share
|
Apr 01
2014 |
PRSO
|
James Sullivan
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,334 Added 9.34% |
-
|
Apr 01
2014 |
COST
|
Franz E Lazarus
Executive VP |
SELL
Open market or private sale
|
Indirect | 600 Reduced 2.18% |
$67,296
$112.16 p/Share
|
Apr 01
2014 |
SPOK
|
Nathaniel Blair Butterfield
Director |
BUY
Grant, award, or other acquisition
|
Direct | 826 Added 23.63% |
$15,008
$18.17 p/Share
|
Apr 01
2014 |
SPOK
|
Royce Yudkoff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 826 Added 3.17% |
$15,008
$18.17 p/Share
|
Apr 01
2014 |
SPOK
|
Samme L Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 826 Added 3.3% |
$15,008
$18.17 p/Share
|
Apr 01
2014 |
SPOK
|
Matthew Oristano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 826 Added 5.42% |
$15,008
$18.17 p/Share
|
Apr 01
2014 |
SPOK
|
Brian Oreilly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 826 Added 5.53% |
$15,008
$18.17 p/Share
|
Apr 01
2014 |
SPOK
|
Nicholas A Gallopo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 963 Added 3.26% |
$17,498
$18.17 p/Share
|
Apr 01
2014 |
IBCP
|
Charles A Palmer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 513 Added 0.72% |
$6,659
$12.98 p/Share
|
Apr 01
2014 |
IBCP
|
Robert L Hetzler
Director |
BUY
Grant, award, or other acquisition
|
Direct | 988 Added 1.82% |
$12,824
$12.98 p/Share
|
Apr 01
2014 |
IBCP
|
Terry L Haske
Director |
BUY
Grant, award, or other acquisition
|
Direct | 494 Added 1.55% |
$6,412
$12.98 p/Share
|
Apr 01
2014 |
IBCP
|
William J Boer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 494 Added 2.45% |
$6,412
$12.98 p/Share
|
Apr 01
2014 |
JNJ
|
Stephen J Cosgrove
Corporate Controller |
BUY
Other acquisition or disposition
|
Indirect | 15 Added 2.93% |
-
|
Mar 31
2014 |
ORCL
|
Thomas Kurian
President-Product Development |
BUY
Other acquisition or disposition
|
Direct | 631 Added 1.88% |
$23,719
$37.59 p/Share
|
Mar 31
2014 |